Recombinant human-activated protein C (rhAPC) in childhood sepsis.
Frassica
Joseph J
JJ
Vinagre
Yuka M
YM
Maas
Barbara
B
D000367:Age Factors; D002648:Child; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D011486:Protein C / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D012449:Safety; D018805:Sepsis / Q000188:drug therapy* / Q000401:mortality
D005343:Fibrinolytic Agents; D011486:Protein C; D011994:Recombinant Proteins; C421124:drotrecogin alfa activated